In a recent study by Cho et al., it was revealed that engineered exosomes derived from primary CD8+ T cells expressing IL-2 and anti-EGFR antibodies not only demonstrated potent antitumor effects on A549 human lung cancer cells but also exhibited an augmented capacity for cancer targetability34. Here, IL2 is linked to cancer.